Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer
- Resource Type
- Article
- Source
- In
International Journal of Radiation Oncology, Biology, Physics 1 May 2022 113(1):60-65 - Subject
- Language
- ISSN
- 0360-3016